European experts on Monday said that Xenical, Roche Holding's obesity treatment, reduced blood pressure in people with hypertension, unlike its rival Meridia, Abbott Laboratories' appetite suppressant. The findings were from a meta-analysis of published reports that assessed the effects of weight-loss treatments on such patients.

Full Story:

Related Summaries